Literature DB >> 3602314

Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.

P J McGrath, J W Stewart, W Harrison, F M Quitkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3602314

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  9 in total

1.  The role of monoamine oxidase inhibitors in current psychiatric practice.

Authors:  Jess G Fiedorowicz; Karen L Swartz
Journal:  J Psychiatr Pract       Date:  2004-07       Impact factor: 1.325

2.  Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine.

Authors:  William V Bobo; Patricio Riva-Posse; Fernando S Goes; Sagar V Parikh
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

3.  Antidepressant failure: augmentation or substitution?

Authors:  R T Joffe; A J Levitt
Journal:  J Psychiatry Neurosci       Date:  1995-01       Impact factor: 6.186

Review 4.  If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.

Authors:  K Ryan Connolly; Michael E Thase
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

5.  Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.

Authors:  Antonio Tundo; Rocco de Filippis; Luca Proietti
Journal:  World J Psychiatry       Date:  2015-09-22

6.  Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.

Authors:  Andre R Brunoni; Renerio Fraguas; Felipe Fregni
Journal:  Ther Clin Risk Manag       Date:  2009-11-18       Impact factor: 2.423

7.  Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.

Authors:  Lina Chiuccariello; Robert G Cooke; Laura Miler; Robert D Levitan; Glen B Baker; Stephen J Kish; Nathan J Kolla; Pablo M Rusjan; Sylvain Houle; Alan A Wilson; Jeffrey H Meyer
Journal:  Int J Neuropsychopharmacol       Date:  2015-08-27       Impact factor: 5.176

Review 8.  Management of Treatment-Resistant Depression: Challenges and Strategies.

Authors:  Daphne Voineskos; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

9.  Transdermal selegiline for the treatment of major depressive disorder.

Authors:  Kelly C Lee; Jack J Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.